Invention Grant
- Patent Title: Bisbubstrate inhibitors of kinases
- Patent Title (中): 双底物激酶抑制剂
-
Application No.: US09811870Application Date: 2001-03-21
-
Publication No.: US07045617B2Publication Date: 2006-05-16
- Inventor: Philip A. Cole , Keykavous Parang , Ararat Abloogu , Ronald A. Kohanski , Aliya Courtney
- Applicant: Philip A. Cole , Keykavous Parang , Ararat Abloogu , Ronald A. Kohanski , Aliya Courtney
- Applicant Address: US NY New York US MD Baltimore
- Assignee: Mount Sinai School of Medicine,Johns Hopkins University
- Current Assignee: Mount Sinai School of Medicine,Johns Hopkins University
- Current Assignee Address: US NY New York US MD Baltimore
- Agency: Banner & Witcoff, Ltd.
- Main IPC: C07H19/20
- IPC: C07H19/20 ; A61K38/28 ; A61K38/00 ; A61K38/04

Abstract:
Protein kinase inhibitors have applications as anti-cancer therapeutic agents and biological tools in cell signalling. Potent and selective bisubstrate inhibitors for the insulin receptor tyrosine kinase are based on a phosphoryl transfer mechanism involving a dissociative transition state. One such inhibitor is synthesized by linking ATPγS to a peptide substrate analog via a two-carbon spacer. The compound is a high-affinity competitive inhibitor against both nucleotide and peptide substrate and shows a slow off-rate. A crystal structure of this inhibitor bound to the tyrosine kinase domain of the insulin receptor confirms the key design features inspired by a dissociative transition state, and reveal that the linker takes part in the octahedral coordination of an active site Mg2+ ion.
Public/Granted literature
- US20020031820A1 Bisbubstrate inhibitors of kinases Public/Granted day:2002-03-14
Information query
IPC分类: